213 related articles for article (PubMed ID: 31979415)
1. Disruption of the Unique ABCG-Family NBD:NBD Interface Impacts Both Drug Transport and ATP Hydrolysis.
Kapoor P; Briggs DA; Cox MH; Kerr ID
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979415
[TBL] [Abstract][Full Text] [Related]
2. Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation.
Ozvegy C; Váradi A; Sarkadi B
J Biol Chem; 2002 Dec; 277(50):47980-90. PubMed ID: 12374800
[TBL] [Abstract][Full Text] [Related]
3. The structure of the human ABC transporter ABCG2 reveals a novel mechanism for drug extrusion.
Khunweeraphong N; Stockner T; Kuchler K
Sci Rep; 2017 Oct; 7(1):13767. PubMed ID: 29061978
[TBL] [Abstract][Full Text] [Related]
4. Effects of putative catalytic base mutation E211Q on ABCG2-mediated methotrexate transport.
Hou YX; Li CZ; Palaniyandi K; Magtibay PM; Homolya L; Sarkadi B; Chang XB
Biochemistry; 2009 Sep; 48(38):9122-31. PubMed ID: 19691360
[TBL] [Abstract][Full Text] [Related]
5. Picky ABCG5/G8 and promiscuous ABCG2 - a tale of fatty diets and drug toxicity.
Khunweeraphong N; Mitchell-White J; Szöllősi D; Hussein T; Kuchler K; Kerr ID; Stockner T; Lee JY
FEBS Lett; 2020 Dec; 594(23):4035-4058. PubMed ID: 32978801
[TBL] [Abstract][Full Text] [Related]
6. The linker region of breast cancer resistance protein ABCG2 is critical for coupling of ATP-dependent drug transport.
Macalou S; Robey RW; Jabor Gozzi G; Shukla S; Grosjean I; Hegedus T; Ambudkar SV; Bates SE; Di Pietro A
Cell Mol Life Sci; 2016 May; 73(9):1927-37. PubMed ID: 26708291
[TBL] [Abstract][Full Text] [Related]
7. Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2.
Henriksen U; Gether U; Litman T
J Cell Sci; 2005 Apr; 118(Pt 7):1417-26. PubMed ID: 15769853
[TBL] [Abstract][Full Text] [Related]
8. Residues contributing to drug transport by ABCG2 are localised to multiple drug-binding pockets.
Cox MH; Kapoor P; Briggs DA; Kerr ID
Biochem J; 2018 May; 475(9):1553-1567. PubMed ID: 29661915
[TBL] [Abstract][Full Text] [Related]
9. Structure of the Human Cholesterol Transporter ABCG1.
Skarda L; Kowal J; Locher KP
J Mol Biol; 2021 Oct; 433(21):167218. PubMed ID: 34461069
[TBL] [Abstract][Full Text] [Related]
10. Cryo-EM structures of a human ABCG2 mutant trapped in ATP-bound and substrate-bound states.
Manolaridis I; Jackson SM; Taylor NMI; Kowal J; Stahlberg H; Locher KP
Nature; 2018 Nov; 563(7731):426-430. PubMed ID: 30405239
[TBL] [Abstract][Full Text] [Related]
11. Single-nucleotide polymorphisms in a short basic motif in the ABC transporter ABCG2 disable its trafficking out of endoplasmic reticulum and reduce cell resistance to anticancer drugs.
Zhang W; Yang Y; Dong Z; Shi Z; Zhang JT
J Biol Chem; 2019 Dec; 294(52):20222-20232. PubMed ID: 31719146
[TBL] [Abstract][Full Text] [Related]
12. D-helix influences dimerization of the ATP-binding cassette (ABC) transporter associated with antigen processing 1 (TAP1) nucleotide-binding domain.
Vakkasoglu AS; Srikant S; Gaudet R
PLoS One; 2017; 12(5):e0178238. PubMed ID: 28542489
[TBL] [Abstract][Full Text] [Related]
13. Structural Basis of Drug Recognition by the Multidrug Transporter ABCG2.
Kowal J; Ni D; Jackson SM; Manolaridis I; Stahlberg H; Locher KP
J Mol Biol; 2021 Jun; 433(13):166980. PubMed ID: 33838147
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the function of the multidrug resistance-linked ATP-binding cassette transporter ABCG2 by the cancer chemopreventive agent curcumin.
Chearwae W; Shukla S; Limtrakul P; Ambudkar SV
Mol Cancer Ther; 2006 Aug; 5(8):1995-2006. PubMed ID: 16928820
[TBL] [Abstract][Full Text] [Related]
15. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
16. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of the N-terminal nucleotide binding domain of an ABC drug transporter of Candida albicans: uncommon cysteine 193 of Walker A is critical for ATP hydrolysis.
Jha S; Karnani N; Dhar SK; Mukhopadhayay K; Shukla S; Saini P; Mukhopadhayay G; Prasad R
Biochemistry; 2003 Sep; 42(36):10822-32. PubMed ID: 12962507
[TBL] [Abstract][Full Text] [Related]
18. A new porphyrin as selective substrate-based inhibitor of breast cancer resistance protein (BCRP/ABCG2).
Zattoni IF; Kronenberger T; Kita DH; Guanaes LD; Guimarães MM; de Oliveira Prado L; Ziasch M; Vesga LC; Gomes de Moraes Rego F; Picheth G; Gonçalves MB; Noseda MD; Ducatti DRB; Poso A; Robey RW; Ambudkar SV; Moure VR; Gonçalves AG; Valdameri G
Chem Biol Interact; 2022 Jan; 351():109718. PubMed ID: 34717915
[TBL] [Abstract][Full Text] [Related]
19. Derivative of 5-cyano-6-phenylpyrimidin antagonizes ABCB1- and ABCG2-mediated multidrug resistance.
Wang JQ; Wang B; Lei ZN; Teng QX; Li JY; Zhang W; Ji N; Cai CY; Ma LY; Liu HM; Chen ZS
Eur J Pharmacol; 2019 Nov; 863():172611. PubMed ID: 31476282
[TBL] [Abstract][Full Text] [Related]
20. Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells.
Gupta P; Zhang YK; Zhang XY; Wang YJ; Lu KW; Hall T; Peng R; Yang DH; Xie N; Chen ZS
Cell Physiol Biochem; 2018; 45(4):1515-1528. PubMed ID: 29486476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]